AU6802801A - Secreted and transmembrane polypeptides and nucleic acids encoding the same - Google Patents
Secreted and transmembrane polypeptides and nucleic acids encoding the sameInfo
- Publication number
- AU6802801A AU6802801A AU6802801A AU6802801A AU6802801A AU 6802801 A AU6802801 A AU 6802801A AU 6802801 A AU6802801 A AU 6802801A AU 6802801 A AU6802801 A AU 6802801A AU 6802801 A AU6802801 A AU 6802801A
- Authority
- AU
- Australia
- Prior art keywords
- secreted
- same
- nucleic acids
- acids encoding
- transmembrane polypeptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70532—B7 molecules, e.g. CD80, CD86
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (40)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2000/005601 WO2000056889A2 (en) | 1999-03-23 | 2000-03-01 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| PCT/US2000/005841 WO2000053758A2 (en) | 1999-03-08 | 2000-03-02 | Compositions and methods for the treatment of immune related diseases |
| US18720200P | 2000-03-03 | 2000-03-03 | |
| US18696800P | 2000-03-06 | 2000-03-06 | |
| US18932800P | 2000-03-14 | 2000-03-14 | |
| US18932000P | 2000-03-14 | 2000-03-14 | |
| PCT/US2000/006884 WO2001005972A1 (en) | 1999-07-20 | 2000-03-15 | Compositions and methods for the treatment of immune related diseases |
| US19082800P | 2000-03-21 | 2000-03-21 | |
| US19104800P | 2000-03-21 | 2000-03-21 | |
| US19131400P | 2000-03-21 | 2000-03-21 | |
| US19100700P | 2000-03-21 | 2000-03-21 | |
| US19265500P | 2000-03-28 | 2000-03-28 | |
| US19305300P | 2000-03-29 | 2000-03-29 | |
| US19303200P | 2000-03-29 | 2000-03-29 | |
| PCT/US2000/008439 WO2000073454A1 (en) | 1999-06-02 | 2000-03-30 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US19464700P | 2000-04-04 | 2000-04-04 | |
| US19444900P | 2000-04-04 | 2000-04-04 | |
| US19669000P | 2000-04-11 | 2000-04-11 | |
| US19682000P | 2000-04-11 | 2000-04-11 | |
| US19618700P | 2000-04-11 | 2000-04-11 | |
| US19597500P | 2000-04-11 | 2000-04-11 | |
| US19600000P | 2000-04-11 | 2000-04-11 | |
| US19812100P | 2000-04-18 | 2000-04-18 | |
| US19858500P | 2000-04-18 | 2000-04-18 | |
| US19965400P | 2000-04-25 | 2000-04-25 | |
| US19939700P | 2000-04-25 | 2000-04-25 | |
| US19955000P | 2000-04-25 | 2000-04-25 | |
| US20151600P | 2000-05-03 | 2000-05-03 | |
| PCT/US2000/013705 WO2000073445A2 (en) | 1999-06-02 | 2000-05-17 | Interleukin-1-receptor associated kinase-3 (irak3) |
| PCT/US2000/014042 WO2000077037A2 (en) | 1999-06-15 | 2000-05-22 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| PCT/US2000/014941 WO2000073348A2 (en) | 1999-06-02 | 2000-05-30 | Methods and compositions for inhibiting neoplastic cell growth |
| PCT/US2000/015264 WO2000073452A2 (en) | 1999-06-02 | 2000-06-02 | Compositions and methods for the treatment of immune related diseases |
| US20983200P | 2000-06-05 | 2000-06-05 | |
| PCT/US2000/020710 WO2001009327A2 (en) | 1999-07-28 | 2000-07-28 | Method of preventing the injury or death of retinal cells and treating ocular diseases |
| US64484800A | 2000-08-22 | 2000-08-22 | |
| PCT/US2000/023328 WO2001016318A2 (en) | 1999-09-01 | 2000-08-24 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| PCT/US2000/030952 WO2001049715A2 (en) | 2000-01-06 | 2000-11-08 | Methods and compositions for inhibiting neoplastic cell growth |
| PCT/US2000/032678 WO2001040466A2 (en) | 1999-12-01 | 2000-12-01 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| PCT/US2000/034956 WO2001046420A2 (en) | 1999-12-23 | 2000-12-20 | Il-17 and il-17r homologous polypeptides and therapeutic uses thereof |
| PCT/US2001/006520 WO2001068848A2 (en) | 2000-03-01 | 2001-02-28 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU6802801A true AU6802801A (en) | 2001-09-24 |
Family
ID=40231083
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU6802801A Pending AU6802801A (en) | 2000-03-01 | 2000-11-29 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| AU2001268028A Abandoned AU2001268028A1 (en) | 2000-03-01 | 2001-02-28 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001268028A Abandoned AU2001268028A1 (en) | 2000-03-01 | 2001-02-28 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1259614A2 (enExample) |
| JP (3) | JP2004508805A (enExample) |
| AU (2) | AU6802801A (enExample) |
| CA (10) | CA2533903A1 (enExample) |
| WO (1) | WO2001068848A2 (enExample) |
Families Citing this family (99)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999009155A1 (en) | 1997-08-19 | 1999-02-25 | Human Genome Sciences, Inc. | 70 human secreted proteins |
| US7057017B2 (en) | 1997-04-16 | 2006-06-06 | Millennium Pharmaceuticals, Inc. | Human dickkopf-related protein and nucleic acid molecules and uses therefor |
| JP4357738B2 (ja) | 1997-09-12 | 2009-11-04 | アポテック エール エ デ− エス.アー. | システインリッチなレセプターであるtrain |
| AU9482498A (en) * | 1997-09-17 | 1999-04-05 | Human Genome Sciences, Inc. | Interleukin-17 receptor-like protein |
| US6849719B2 (en) | 1997-09-17 | 2005-02-01 | Human Genome Sciences, Inc. | Antibody to an IL-17 receptor like protein |
| US20030039648A1 (en) | 1998-09-16 | 2003-02-27 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| US20030130182A1 (en) * | 1997-11-05 | 2003-07-10 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US7446181B2 (en) | 1998-01-15 | 2008-11-04 | Millennium Pharmaceuticals, Inc. | Antibodies that bind human Dickkopf-1 proteins |
| NZ508878A (en) | 1998-05-15 | 2003-08-29 | Genentech Inc | IL-17B and IL-17Cactive variants of IL-17 which stimulates epithelial, endothelial and fibroblastic cells |
| US7771719B1 (en) | 2000-01-11 | 2010-08-10 | Genentech, Inc. | Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E |
| US6344541B1 (en) | 1998-09-25 | 2002-02-05 | Amgen Inc. | DKR polypeptides |
| US6291663B1 (en) * | 1999-03-03 | 2001-09-18 | Board Of Trustees Of The University Of Arkansas | TADG-12: a novel transmembrane serine protease overexpressed in a ovarian carcinoma |
| US7109292B2 (en) | 1999-03-08 | 2006-09-19 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US8133734B2 (en) | 1999-03-16 | 2012-03-13 | Human Genome Sciences, Inc. | Kit comprising an antibody to interleukin 17 receptor-like protein |
| JP2002543838A (ja) * | 1999-05-13 | 2002-12-24 | メディカル リサーチ カウンシル | Ox2レセプターホモログ |
| US7034132B2 (en) | 2001-06-04 | 2006-04-25 | Anderson David W | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| EP1623992A3 (en) * | 1999-09-01 | 2006-05-10 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| JP2003514524A (ja) | 1999-11-18 | 2003-04-22 | コルバス・インターナショナル・インコーポレイテッド | エントセリアーゼをコードしている核酸、エンドセリアーゼおよびその使用 |
| EP1897945B1 (en) * | 1999-12-23 | 2012-01-18 | Genentech, Inc. | IL-17 homologous polypeptides and therapeutic uses thereof |
| US20040043397A1 (en) | 2000-01-11 | 2004-03-04 | Genentech, Inc. | IL-17 homologous polypeptides and therapeutic uses thereof |
| US20020155499A1 (en) * | 2000-09-25 | 2002-10-24 | Leiby Kevin R. | 32624, a novel human UDP-glucuronosyl and glycosyl transferase family member and uses thereof |
| US20020164745A1 (en) * | 2000-06-15 | 2002-11-07 | Meyers Rachel A. | 53320, a novel human acyltransferase and uses therefor |
| US7094566B2 (en) | 2000-03-16 | 2006-08-22 | Amgen Inc., | IL-17 receptor like molecules and uses thereof |
| US7718397B2 (en) | 2000-03-21 | 2010-05-18 | Genentech, Inc. | Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof |
| EP1280923A2 (en) | 2000-04-28 | 2003-02-05 | Millennium Pharmaceuticals, Inc. | 14094, a human trypsin family member and uses thereof |
| US20030096969A1 (en) | 2000-06-02 | 2003-05-22 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US6965018B2 (en) | 2000-06-06 | 2005-11-15 | Bristol-Myers Squibb Company | Antibodies directed to B7-related polypeptide, BSL-2 |
| US20030031675A1 (en) | 2000-06-06 | 2003-02-13 | Mikesell Glen E. | B7-related nucleic acids and polypeptides useful for immunomodulation |
| JP2004500872A (ja) * | 2000-06-22 | 2004-01-15 | バイオジェン インコーポレイテッド | Gp354核酸およびポリペプチド |
| US20020061574A1 (en) * | 2000-09-01 | 2002-05-23 | Rachel Meyers | 16658, 14223, and 16002, novel human kinases and uses therefor |
| AU2001273194A1 (en) * | 2000-06-30 | 2002-01-14 | Amgen Inc. | B7-Like Molecules and Uses Thereof |
| WO2002010217A2 (en) | 2000-08-02 | 2002-02-07 | The Johns Hopkins University | Endothelial cell expression patterns |
| CA2420392A1 (en) * | 2000-08-28 | 2002-03-07 | Human Genome Sciences, Inc. | 17 human secreted proteins |
| EP1334179A2 (en) | 2000-11-14 | 2003-08-13 | Bristol-Myers Squibb Company | A human serpin secreted from lymphoid cells lsi-01 |
| DE10106835A1 (de) * | 2001-02-14 | 2002-09-05 | Basf Lynx Bioscience Ag | Signaltransduktionsproteine 15B3, 15B3-1 und 15B3-2 und zugrundeliegende DNA-Sequenzen |
| WO2002064769A1 (en) * | 2001-02-15 | 2002-08-22 | Shionogi & Co., Ltd. | Novel disease marker |
| EP1873245A1 (en) * | 2001-02-28 | 2008-01-02 | Genentech, Inc. | Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| AU2002257088A1 (en) * | 2001-03-12 | 2002-09-24 | Incyte Genomics, Inc. | Immunoglobulin superfamily proteins |
| WO2002072786A2 (en) | 2001-03-13 | 2002-09-19 | Corvas International, Inc. | Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon |
| CA2441378A1 (en) | 2001-03-22 | 2002-10-03 | Dendreon San Diego Llc | Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon |
| US7105333B2 (en) | 2001-03-27 | 2006-09-12 | Deadreon Corporation | Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon |
| US7033790B2 (en) | 2001-04-03 | 2006-04-25 | Curagen Corporation | Proteins and nucleic acids encoding same |
| US7736654B2 (en) | 2001-04-10 | 2010-06-15 | Agensys, Inc. | Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
| WO2002083856A2 (en) | 2001-04-11 | 2002-10-24 | Bristol-Myers Squibb Company | Polynucleotides encoding two novel human g-protein coupled receptors, hgprbmy28 and hgprbmy29, and splice variants thereof |
| JP2005506832A (ja) | 2001-05-14 | 2005-03-10 | デンドレオン・サンディエゴ・リミテッド・ライアビリティ・カンパニー | トランスメンブランセリンプロテアーゼ10をコードする核酸分子、コードされるポリペプチドおよびそれに基づく方法 |
| WO2002101075A2 (en) | 2001-06-13 | 2002-12-19 | Millennium Pharmaceuticals, Inc. | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| WO2003000021A2 (en) * | 2001-06-22 | 2003-01-03 | Biogen, Inc. | Pancam nucleic acids and polypeptides |
| WO2003004530A1 (en) * | 2001-07-06 | 2003-01-16 | Bayer Aktiengesellschaft | Regulation of human somatostatin receptor-like protein |
| IL159872A0 (en) * | 2001-07-26 | 2004-06-20 | Genset Sa | Gmg-2 polypeptides and their use |
| JP4702819B2 (ja) | 2001-08-01 | 2011-06-15 | 生化学工業株式会社 | コンドロイチン合成酵素 |
| JP4102898B2 (ja) * | 2001-08-23 | 2008-06-18 | 独立行政法人科学技術振興機構 | 造血幹細胞増殖調節因子及びそれをコードするポリヌクレオチド |
| WO2003099318A2 (en) | 2002-05-29 | 2003-12-04 | DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung | Pancreas-specific proteins |
| KR101008758B1 (ko) | 2001-09-18 | 2011-01-14 | 제넨테크, 인크. | 종양의 진단 및 치료를 위한 방법 및 이를 위한 조성물 |
| WO2003025162A2 (en) * | 2001-09-20 | 2003-03-27 | Bayer Healthcare Ag | Regulation of human prolyl 4-hydroxylase alpha subunit precursor |
| JP2005508171A (ja) * | 2001-11-02 | 2005-03-31 | タノックス インコーポレーテッド | B細胞悪性病変の診断及び予防に用いるためのb細胞リンパ腫特異抗原 |
| US7396662B2 (en) | 2001-12-19 | 2008-07-08 | Immunex Corporation | C-type lectin polypeptides |
| DE10211088A1 (de) * | 2002-03-13 | 2003-09-25 | Ugur Sahin | Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung |
| AU2002254651A1 (en) * | 2002-04-17 | 2003-11-03 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| US7232676B2 (en) * | 2002-05-31 | 2007-06-19 | Seikagaku Kogyo Kabushiki Kaisha | Chondroitin synthase and nucleic acid encoding the enzyme |
| WO2003102182A1 (en) * | 2002-05-31 | 2003-12-11 | Hidetoshi Inoko | Inflammatory skin disease-related slurp-2 gene and utilization thereof |
| EP2305710A3 (en) | 2002-06-03 | 2013-05-29 | Genentech, Inc. | Synthetic antibody phage libraries |
| DE10242016A1 (de) * | 2002-09-11 | 2004-03-25 | Esplora GmbH c/o TU Darmstadt Institut für Biochemie | Verfahren zur Identifizierung BHS-spezifischer Proteine und Fragmente davon |
| EP1575497A4 (en) * | 2002-09-11 | 2010-11-03 | Genentech Inc | NEW COMPOSITION AND METHOD FOR TREATING PSORIASIS |
| DE10254601A1 (de) | 2002-11-22 | 2004-06-03 | Ganymed Pharmaceuticals Ag | Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung |
| KR20050085881A (ko) * | 2002-12-26 | 2005-08-29 | 다케다 야쿠힌 고교 가부시키가이샤 | 신규 단백질 및 그 용도 |
| WO2004063226A2 (en) * | 2002-12-27 | 2004-07-29 | Applied Research Systems Ars Holding N.V. | Novel fibrillin-like polypeptides |
| WO2004064740A2 (en) * | 2003-01-16 | 2004-08-05 | University Of Virginia Patent Foundation | Sperm specific lysozyme-like proteins |
| US7312197B2 (en) | 2003-02-24 | 2007-12-25 | University Of Maryland, Baltimore | Method of modifying glucose activity using polypeptides selectively expressed in fat tissue |
| US20040185559A1 (en) | 2003-03-21 | 2004-09-23 | Isis Pharmaceuticals Inc. | Modulation of diacylglycerol acyltransferase 1 expression |
| US20050025763A1 (en) | 2003-05-08 | 2005-02-03 | Protein Design Laboratories, Inc. | Therapeutic use of anti-CS1 antibodies |
| US7709610B2 (en) | 2003-05-08 | 2010-05-04 | Facet Biotech Corporation | Therapeutic use of anti-CS1 antibodies |
| EP1641822B1 (en) | 2003-07-08 | 2013-05-15 | Genentech, Inc. | Il-17 a/f heterologous polypeptides and therapeutic uses thereof |
| AU2004266246A1 (en) | 2003-08-14 | 2005-03-03 | Dyax Corp. | Endotheliase-2 ligands |
| US7825235B2 (en) | 2003-08-18 | 2010-11-02 | Isis Pharmaceuticals, Inc. | Modulation of diacylglycerol acyltransferase 2 expression |
| EP1712619A4 (en) * | 2003-12-24 | 2008-01-02 | Takeda Pharmaceutical | MEANS FOR PREVENTING / CUREING CANCER |
| DE102004024617A1 (de) | 2004-05-18 | 2005-12-29 | Ganymed Pharmaceuticals Ag | Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung |
| CN101010342A (zh) | 2004-07-02 | 2007-08-01 | 健泰科生物技术公司 | 用于治疗非何杰金淋巴瘤的组合物和方法 |
| WO2006017673A2 (en) | 2004-08-03 | 2006-02-16 | Biogen Idec Ma Inc. | Taj in neuronal function |
| ES2414460T3 (es) | 2004-08-04 | 2013-07-19 | Amgen Inc. | Anticuerpos para Dkk-1 |
| US7544659B2 (en) | 2004-08-13 | 2009-06-09 | Genentech, Inc. | Promotion of axonal regeneration |
| US20110097330A1 (en) * | 2005-03-11 | 2011-04-28 | Genentech, Inc. | Novel Gene Disruptions, Compostitions and Methods Relating Thereto |
| EP1790664A1 (en) | 2005-11-24 | 2007-05-30 | Ganymed Pharmaceuticals AG | Monoclonal antibodies against claudin-18 for treatment of cancer |
| CA2630483C (en) | 2005-12-08 | 2015-05-19 | Medarex, Inc. | Human monoclonal antibodies to o8e |
| WO2007107774A2 (en) * | 2006-03-22 | 2007-09-27 | Cartela R & D Ab | Integrin alpha-10 subunit as therapeutic target and diagnostic/prognostic marker for cancer |
| CA2649387A1 (en) * | 2006-04-19 | 2008-03-27 | Genentech, Inc. | Novel gene disruptions, compositions and methods relating thereto |
| WO2008019351A2 (en) | 2006-08-04 | 2008-02-14 | Isis Pharmaceuticals, Inc. | Compositions and their uses directed to diacylglycerol acyltransferase 1 |
| ES2625259T3 (es) | 2006-08-29 | 2017-07-19 | Oxford Biotherapeutics Ltd | Identificación de proteína asociada con carcinoma hepatocelular, glioblastoma y cáncer de pulmón |
| US8058014B2 (en) | 2006-09-29 | 2011-11-15 | University Of Maryland, Baltimore | Method of diagnosing or predicting disease states in a subject using omentin 1 and omentin 2 |
| KR20170023209A (ko) | 2008-05-05 | 2017-03-02 | 노비뮨 에스 에이 | 항-il-17a/il-17f 교차-반응성 항체 및 그의 사용 방법 |
| JP2011523560A (ja) | 2008-06-02 | 2011-08-18 | ダナ−ファーバー キャンサー インスティテュート インク. | Xbp1ペプチド、cd138ペプチドおよびcs1ペプチド |
| BRPI1009232B1 (pt) | 2009-03-05 | 2022-05-03 | E.R. Squibb & Sons, Llc. | Anticorpo monoclonal isolado ou uma porção de ligação de antígeno do mesmo, ou um fragmento de anticorpo, composição que os compreende, molécula de ácido nucleico, hibridoma e métodos para a preparação de um anticorpo anti-cadm1 |
| PE20120815A1 (es) | 2009-05-05 | 2012-07-08 | Novimmune Sa | Anticuerpos anti il-17f y metodos de uso de los mismos |
| WO2013167153A1 (en) | 2012-05-09 | 2013-11-14 | Ganymed Pharmaceuticals Ag | Antibodies useful in cancer diagnosis |
| WO2013174404A1 (en) | 2012-05-23 | 2013-11-28 | Ganymed Pharmaceuticals Ag | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
| CN105377288B (zh) | 2012-11-05 | 2019-11-15 | 达纳-法伯癌症研究所股份有限公司 | Xbp1、cd138和cs1肽的组合物制备药物的用途 |
| UA128182C2 (uk) | 2012-11-13 | 2024-05-01 | Біонтех Аґ | Агенти для лікування експресуючих клаудин ракових захворювань |
| WO2014127785A1 (en) | 2013-02-20 | 2014-08-28 | Ganymed Pharmaceuticals Ag | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
| WO2014146672A1 (en) | 2013-03-18 | 2014-09-25 | Ganymed Pharmaceuticals Ag | Therapy involving antibodies against claudin 18.2 for treatment of cancer |
| PE20180800A1 (es) | 2015-07-10 | 2018-05-09 | Ionis Pharmaceuticals Inc | Moduladores de diaciglicerol aciltransferasa 2 (dgat2) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19817948A1 (de) * | 1998-04-17 | 1999-10-21 | Metagen Gesellschaft Fuer Genomforschung Mbh | Menschliche Nukleinsäuresequenzen aus Endometrium-Tumor |
| IL139686A0 (en) * | 1998-06-02 | 2002-02-10 | Genentech Inc | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| JP2004507202A (ja) * | 1999-03-31 | 2004-03-11 | キュラジェン コーポレイション | ポリペプチドをコードするオープンリーディングフレームを含む核酸;「orfx」 |
| JP2004522402A (ja) * | 1999-06-02 | 2004-07-29 | ジェネンテック・インコーポレーテッド | 同一のものをコードする分泌及び膜貫通ポリペプチドと核酸 |
| EP1248800A2 (en) * | 1999-11-30 | 2002-10-16 | Corixa Corporation | Compositions and methods for therapy and diagnosis of breast cancer |
| CA2399776A1 (en) * | 2000-02-03 | 2001-08-09 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
| AU2001270118A1 (en) * | 2000-08-24 | 2002-03-04 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
-
2000
- 2000-11-29 AU AU6802801A patent/AU6802801A/xx active Pending
-
2001
- 2001-02-28 CA CA002533903A patent/CA2533903A1/en not_active Abandoned
- 2001-02-28 CA CA002531917A patent/CA2531917A1/en not_active Abandoned
- 2001-02-28 CA CA002539214A patent/CA2539214A1/en not_active Abandoned
- 2001-02-28 WO PCT/US2001/006520 patent/WO2001068848A2/en not_active Ceased
- 2001-02-28 CA CA002401448A patent/CA2401448A1/en not_active Abandoned
- 2001-02-28 CA CA002534391A patent/CA2534391A1/en not_active Abandoned
- 2001-02-28 JP JP2001567332A patent/JP2004508805A/ja not_active Withdrawn
- 2001-02-28 CA CA002534018A patent/CA2534018A1/en not_active Abandoned
- 2001-02-28 CA CA002533831A patent/CA2533831A1/en not_active Abandoned
- 2001-02-28 CA CA002534186A patent/CA2534186A1/en not_active Abandoned
- 2001-02-28 AU AU2001268028A patent/AU2001268028A1/en not_active Abandoned
- 2001-02-28 CA CA002533991A patent/CA2533991A1/en not_active Abandoned
- 2001-02-28 EP EP01945919A patent/EP1259614A2/en not_active Withdrawn
- 2001-02-28 CA CA002534030A patent/CA2534030A1/en not_active Abandoned
-
2005
- 2005-08-15 JP JP2005264294A patent/JP2006081548A/ja not_active Withdrawn
-
2008
- 2008-06-12 JP JP2008153789A patent/JP2008301822A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CA2401448A1 (en) | 2001-09-20 |
| JP2006081548A (ja) | 2006-03-30 |
| CA2534391A1 (en) | 2001-09-20 |
| CA2539214A1 (en) | 2001-09-20 |
| CA2533903A1 (en) | 2001-09-20 |
| CA2534186A1 (en) | 2001-09-20 |
| EP1259614A2 (en) | 2002-11-27 |
| CA2533991A1 (en) | 2001-09-20 |
| CA2534018A1 (en) | 2001-09-20 |
| WO2001068848A2 (en) | 2001-09-20 |
| WO2001068848A3 (en) | 2002-08-29 |
| AU2001268028A1 (en) | 2001-09-24 |
| JP2008301822A (ja) | 2008-12-18 |
| JP2004508805A (ja) | 2004-03-25 |
| CA2533831A1 (en) | 2001-09-20 |
| CA2534030A1 (en) | 2001-09-20 |
| CA2531917A1 (en) | 2001-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU6802801A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
| AU7315001A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
| AU6531101A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
| AU1661002A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
| IL139686A0 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
| IL188581A0 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
| AU7573000A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
| AU2055401A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
| AU2883700A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
| AU2883900A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
| IL141535A0 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
| EP1490386A4 (en) | NEW POLYPEPTIDES AND THESE ENCODING NUCLEIC ACIDS | |
| AU2002368010A8 (en) | Novel nucleic acids and secreted polypeptides | |
| EP1173456A4 (en) | SECRETED PROTEINS AND NUCLEIC ACIDS ENCODING THEM | |
| AU2002367815A8 (en) | Novel nucleic acids and secreted polypeptides | |
| AU2001249394A1 (en) | Secreted proteins and polynucleotides encoding them | |
| AU2001239889A1 (en) | Polypeptides and nucleic acids encoding same | |
| KR100514265B1 (en) | Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same | |
| KR100532172B1 (en) | Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same | |
| KR100528420B1 (en) | Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same | |
| KR100498658B1 (en) | Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same | |
| AU4587101A (en) | Novel human secreted proteins and polynucleotides encoding the same | |
| AU2001234896A1 (en) | Novel polypeptides and nucleic acids encoding same | |
| IL142673A0 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
| AU5152700A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same |